FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019
X

Overview

Client Email Product
Lactose Monohydrate
  • FDA Inactive Ingredient Details

  • DESCRIPTION

PharmaCompass
Previous
Next
  • FDA Inactive Ingredient Details
  • DESCRIPTION

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
INJECTION
IM - IV
EWQ57Q8I5X
2.5
%

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
POWDER, FOR INJECTION ...
IM - IV
EWQ57Q8I5X
2.5
%

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
POWDER, FOR INJECTION ...
INTRAMUSCULAR
EWQ57Q8I5X
1.05
%

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
INJECTION
INTRAVENOUS
EWQ57Q8I5X
25
%

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
POWDER, FOR INJECTION ...
INTRAVENOUS
EWQ57Q8I5X
75
%

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
POWDER, FOR INJECTION ...
IV(INFUSION)
EWQ57Q8I5X
20
%

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
CAPSULE
ORAL
EWQ57Q8I5X
430.42
MG

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
CAPSULE, HARD GELATIN
ORAL
EWQ57Q8I5X
141
MG

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
CAPSULE, SUSTAINED ACT...
ORAL
EWQ57Q8I5X
147.6
MG

FDA INACTIVE INGREDIENT DATABASE

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

LACTOSE MONOHYDRATE

Contact the Supplier
GRANULE, FOR SUSPENSIO...
ORAL
EWQ57Q8I5X
0
NA

https://www.pharmacompass.com/pdf-document/pubchem/Lactose-Monohydrate123-pubchem-1529486782.pdf

  • WHO-GMP
Applications: Pharmatose® 200M is a highly consistent monohydrate lactose which delivers good compaction properties.This lactose type is typically used in tablets, capsules and extrusion spheronisation.
Ingredient(s): Lactose Monohydrate
Dosage Form: Tablet
More Info on Category: Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph
Technical Specifications: Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90- 120 ?m; Hausner ratio- 1,46
    Applications: HiCellac 100 is used in direct compression, dry granulation & capsule filling, suitable for low dose formulations where API content uniformity is critical. It also provides excellent compaction properties & tablet hardness.
    Ingredient(s): Lactose Monohydrate
    Dosage Form: Tablet
    More Info on Category: Granulation
    Route of Administration (Grade): Oral
    Pharmacopoeia Reference: Not Available
    Technical Specifications: Not Available
      Applications: Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.
      Ingredient(s): Lactose Monohydrate
      Dosage Form: Tablet
      More Info on Category: Granulation
      Route of Administration (Grade): Oral
      Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
      Technical Specifications: Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m
        Applications: It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.
        Ingredient(s): Lactose Monohydrate
        Dosage Form: Tablet
        More Info on Category: Granulation
        Route of Administration (Grade): Oral
        Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
        Technical Specifications: Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s
        Ask Us for Pharmaceutical Supplier and Partner
        Ask Us, Find A Supplier / Partner
        No Commissions, No Strings Attached, Get Connected for FREE

        What are you looking for?

        How can we help you?

        The request can't be empty

        Please read our Privacy Policy carefully

        You must agree to the privacy policy

        The name can't be empty
        The company can't be empty.
        The email can't be empty Please enter a valid email.
        The mobile can't be empty

        Advertise With Us

        Advertise With Us